Bellerophon Therapeutics Publicly Traded Corporation
Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.
Investors
Headquarters:
United States
Employee Number:
12
Ticker:
BLPH